TI
AVBP icon

Trexquant Investment’s ArriVent BioPharma AVBP Stock Holding History

Trexquant Investment’s Portfolio AVBP Stock Details AVBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.5M Buy
+71,860
New +$2.12M 0.01% 1099

Other funds holding AVBP

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $983M AUM 26.53% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Trexquant Investment's AVBP Position: Q2 2026 in Review

Trexquant Investment opened a new position in ArriVent BioPharma (AVBP) in Q2 2026: 71,860 shares worth $2.5M. The stake represents 0.01% of the portfolio and ranks #1099 among its holdings.

157 funds tracked by Wall St. Rank hold AVBP as of Q2 2026.

  • Trexquant Investment held 71,860 shares of ArriVent BioPharma worth $2.5M as of Q2 2026.
  • ArriVent BioPharma was a new Trexquant Investment position in Q2 2026.
  • ArriVent BioPharma made up 0.01% of Trexquant Investment's portfolio in Q2 2026, its #1099 holding.
  • 157 funds tracked by Wall St. Rank held ArriVent BioPharma as of Q2 2026.

Based on Trexquant Investment's 13F filing for Q2 2026, filed 14 Aug 2026.